Evidence map›Paper›PMID 35696583›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.

Kevin MingJie Gao, Mona Motwani, Thomas Tedder, Ann Marshak-Rothstein, Katherine A Fitzgerald

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Endothelial cell expression of STINGThe Journal of investigative dermatology · 2026
    Article
  2. Interstitial lung disease and the STING pathway.The Journal of clinical investigation · 2026
    Review
  3. Autoinflammatory syndromes of STING and TREX1 dysfunction.The Journal of clinical investigation · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The commoneLife · 2024
    Article
  15. Article
  16. Article
  17. The commonbioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kevin MingJie GaoProgram in Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605.ORCID 0000-0001-5855-1006
Mona MotwaniProgram in Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Thomas TedderDepartment of Immunology, Duke University School of Medicine, Durham, NC 22710.
Ann Marshak-RothsteinProgram in Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Katherine A FitzgeraldProgram in Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605.
University of Massachusetts Chan Medical School · USDuke University · US

Funding

Medical Scientist Training at UMMS Administrative SupplementT32GM107000 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIEFE, CATARINA I. · 2013 to 2022
$4.9M
Regulation of Lupus by Cytosolic DNA SensorsR01AI128358 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., MARSHAK-ROTHSTEIN, ANN · 2017 to 2021
$2.7M
Training in the Molecular Basis of Autoimmunity and AutoinflammationT32AI132152 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Katherine A. Fitzgerald, Ann Marshak-Rothstein · 2018 to 2026
$1.6M
Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous LupusR21AI145097 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MARSHAK-ROTHSTEIN, ANN · 2019 to 2020
$461k
Investigating the role of B cells in pulmonary fibrosis resulting from STING gain-of-function autoinflammationF30HL154674 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAO, KEVIN MINGJIE · 2020 to 2022
$114k
NHLBI NIH HHS F30 HL154674NIAID NIH HHS R01 AI128358NIAID NIH HHS R21 AI145097NIAID NIH HHS T32 AI132152NIGMS NIH HHS T32 GM107000
6 · The paper itself

Abstract

Pediatric patients with constitutively active mutations in the cytosolic double-stranded-DNA-sensing adaptor STING develop an autoinflammatory syndrome known as STING-associated vasculopathy with onset in infancy (SAVI). SAVI patients have elevated interferon-stimulated gene expression and suffer from interstitial lung disease (ILD) with lymphocyte predominate bronchus-associated lymphoid tissue (BALT). Mice harboring SAVI mutations (STING V154M [VM]) that recapitulate human disease also develop lymphocyte-rich BALT. Ablation of either T or B lymphocytes prolongs the survival of SAVI mice, but lung immune aggregates persist, indicating that T cells and B cells can independently be recruited as BALT. VM T cells produced IFNγ, and IFNγR deficiency prolonged the survival of SAVI mice; however, T-cell-dependent recruitment of infiltrating myeloid cells to the lung was IFNγ independent. Lethally irradiated VM recipients fully reconstituted with wild type bone-marrow-derived cells still developed ILD, pointing to a critical role for VM-expressing radioresistant parenchymal and/or stromal cells in the recruitment and activation of pathogenic lymphocytes. We identified lung endothelial cells as radioresistant cells that express STING. Transcriptional analysis of VM endothelial cells revealed up-regulation of chemokines, proinflammatory cytokines, and genes associated with antigen presentation. Together, our data show that VM-expressing radioresistant cells play a key role in the initiation of lung disease in VM mice and provide insights for the treatment of SAVI patients, with implications for ILD associated with other connective tissue disorders.

Indexed as

Endothelial CellsLung Diseases, InterstitialMembrane ProteinsT-LymphocytesVascular DiseasesAnimalsChildGain of Function MutationHumansInterferon-gammaLymphocyte DepletionLymphoid TissueMiceRadiation ToleranceSTING ProteinInterferon-gammaMembrane ProteinsSting1 protein, mouseSTING Proteinendothelial cellsinterferon gammainterstitial lung diseaseSAVISTING

Identifiers

PMID35696583
PMCPMC9231608
OpenAlexW4282548240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.